1. Home
  2. SCLXW vs FCNCO Comparison

SCLXW vs FCNCO Comparison

Compare SCLXW & FCNCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

HOLD

Current Price

$0.16

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Logo First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C

FCNCO

First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C

HOLD

Current Price

$21.20

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLXW
FCNCO
Founded
N/A
1898
Country
United States
United States
Employees
31
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLXW
FCNCO
Price
$0.16
$21.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0K
23.8K
Earning Date
03-07-2025
10-23-2025
Dividend Yield
N/A
6.17%
EPS Growth
N/A
N/A
EPS
N/A
169.27
Revenue
$55,152,000.00
$8,897,000,000.00
Revenue This Year
N/A
$0.56
Revenue Next Year
N/A
$2.24
P/E Ratio
N/A
$9.80
Revenue Growth
22.02
N/A
52 Week Low
$0.18
$20.57
52 Week High
$0.18
$24.40

Technical Indicators

Market Signals
Indicator
SCLXW
FCNCO
Relative Strength Index (RSI) 41.02 27.94
Support Level $0.17 $21.12
Resistance Level $0.21 $21.55
Average True Range (ATR) 0.03 0.25
MACD -0.00 -0.11
Stochastic Oscillator 30.64 5.93

Price Performance

Historical Comparison
SCLXW
FCNCO

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About FCNCO First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: